At Virginia Commonwealth University, he oversaw expansion of the faculty roster and physical facilities, as well as of the increased surgical volume and research productivity.
Ophthalmology, a volunteer for ORBIS International, and an investigator for the Advanced Glaucoma Intervention Study. When he received the American Academy of Ophthalmology's Senior Achievement Award in 2000, he was only the second Virginian to do so. He chaired the American Academy of Ophthalmology's Committee on Ophthalmic Drugs and served on the Food and Drug Administration's Advisory Committee on Anti-Infectives and Ophthalmic Drugs.
Outside of ophthalmology, Bob was devoted to his family, including his wife, Janice (a former oncology nurse), and his sons Grant, Matthew, and Connor. He was quite active in church and community affairs, as well as being an avid tennis player, oenophile, and college basketball fan.
In 2000, Bob was diagnosed with ciliochoroidal melanoma. Although his subsequent enucleation forced him to withdraw from a busy surgical practice, he continued his clinical, research, teaching, and administrative duties until the discovery, in 2003, of liver metastases. With a combination of willpower and several innovative treatment regimens (including percutaneous hepatic perfusion with melphalan), Bob survived 22 months, an exceptional length of time with this condition.
During this time, Bob and Grant founded the nonprofit Ocular Melanoma Foundation (www.ocularmelanoma .org), envisioned as a resource for clinicians, researchers, and patients with an interest in the disorder. Hopefully, this organization will flourish and provide significant assistance toward improved treatment of uveal melanoma. This would potentially represent Bob's greatest contribution to ophthalmology, as well as a posthumous victory over his disease.
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